Shilpa Medicare Ltd.
Fundamentals
- Market cap
- ₹11,179 cr
- P/E
- 45.94×
- ROE
- 3.30%
- Debt / equity
- 0.25
- Div yield
- 0.10%
- 52-week range
- 259.50 — 598.90
Shilpa Medicare Ltd.
Latest quarter · Mar 2026
Strength & growth
The timeline — 7 notes on Shilpa Medicare Ltd.
June 2026
- 30 Jun 26 · 10:26 AM IST Lead Lead · Mid cap
Shilpa Medicare partners with Orion for Nivolumab biosimilar in Europe
Shilpa Biologicals will develop and supply the biosimilar; Orion handles EU regulatory and marketing. Originator Nivolumab had $4.1B in European sales in 2025.
- 24 Jun 26 · 9:05 AM IST Lead Lead · Mid cap
Shilpa Medicare commissions ADC facility, targets global CDMO play
The Dharwad plant is fully operational and entering GMP qualification; the company aims to become a cost-competitive CDMO partner for oncology drug makers.
- 03 Jun 26 · 9:31 AM IST Brief Brief · Mid cap
Shilpa Medicare buys 30% of Spanish biotech for €7M, chases a brain-cancer therapy
Its unit Shilpa Biocare acquires a minority stake in Gate2Brain, gaining manufacturing rights for a candidate with orphan drug status from the FDA and EMA.
May 2026
- 26 May 26 · 1:51 PM IST Brief Brief · Earnings · Mid cap
Shilpa Medicare drops Aflibercept Europe trial, delays alopecia drug
The company shelved a costly European trial for one biologic and pushed back a Phase I for another, even as Q4 FY26 hit record revenue.
- 22 May 26 · 5:23 PM IST Brief Brief · Concalls · Mid cap
Shilpa Medicare kills European Aflibercept push, defers Unicycive revenue to FY28
Strong FY26 results couldn't mask a conference call full of delays. Pipeline programs are sliding and the margin target is off the table.
- 22 May 26 · 2:58 PM IST Brief Brief · Earnings · Mid cap
Shilpa Medicare profit hits ₹108 cr as pharma operations turn around
Consolidated net profit grew sevenfold in the March quarter while the company moved to buy a 28% stake in Neo Green Power.
- 22 May 26 · 2:58 PM IST Brief Brief · Earnings · Mid cap
Shilpa Medicare profit triples to ₹243 cr
Consolidated profits surged behind an improved operating performance and a one-time stake sale, while management targets captive energy savings.